Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Abatacept in Inflammatory Polyarthritis of Systemic Lupus Erythematosus (SLE)

NCT02429934 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT02429934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02429934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Abatacept in Inflammatory Polyarthritis of Systemic Lupus Erythematosus (SLE)
Lead sponsor
University of California, Los Angeles
Phase
Phase 1/2
Overall status
Terminated
Start date
October 31, 2015
Completion date
September 1, 2019
Enrollment
28 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus arthritis